PIER 88 INVESTMENT PARTNERS LLC

Position in ABCL — AbCellera Biologics Inc.

CIK 1697366 SAN FRANCISCO, CA

Position in ABCL

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$627,215

+$208,066 QoQ

Shares Held

79,900

-33.5% QoQ

Ownership

0.026%

of shares outstanding

% of Portfolio

0.81%

of 13F equity value

Holder Rank

#57

of 150 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PIER 88 INVESTMENT PARTNERS LLC holds $6,341,408 across 13 Biotechnology names. ABCL ranks #5 (9.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	2,400	$892,008
2	LGND	Ligand Pharmaceuticals Inc	2,600	$821,834
3	MDGL	Madrigal Pharmaceuticals, Inc.	1,300	$698,035
4	HALO	Halozyme Therapeutics, Inc.	8,500	$665,295
5	ABCL	AbCellera Biologics Inc. This page	79,900	$627,215
6	ABSI	Absci Corp	42,500	$492,575
7	BBIO	BridgeBio Pharma, Inc.	6,300	$469,224
8	CORT	Corcept Therapeutics Inc	4,100	$356,495

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$627,215	79,900	-33.5%	Shares	Sole	2026-08-04
2026-03-31	$419,149	120,100	+13.6%	Shares	Sole	2026-05-11
2025-12-31	$361,596	105,730	-2.9%	Shares	Sole	2026-02-04
2025-09-30	$547,616	108,870	-55.4%	Shares	Sole	2025-10-31
2025-06-30	$837,537	244,180	+0.2%	Shares	Sole	2025-08-07
2025-03-31	$543,651	243,790	+2.9%	Shares	Sole	2025-05-06
2024-12-31	$694,117	236,900	+21.2%	Shares	Sole	2025-02-12
2024-09-30	$508,300	195,500	+21.0%	Shares	Sole	2024-11-06
2024-06-30	$478,395	161,620	+362.0%	Shares	Sole	2024-08-06
2024-03-31	$158,459	34,980	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.